Aug 2026
CTPS1 promotes lung adenocarcinoma progression as a targetable vulnerability.
Targeting CTPS1 with STP938, alone or in combination with osimertinib, represents a promising therapeutic strategy and supports CTPS1 as a targetable vulnerability in lung adenocarcinoma.
Hui Xie, Cai-Xia Xu, Bing-Han Zhou et al.
· British Journal of Cancer · 0 citations